Perioperative Blood Transfusion in Open Liver Resection

Status Completed

Clinical Trial Summary

This observational study is specifically designed to identify the pre-operative risk factors that significantly contribute to perioperative packed red cell transfusions in open liver resection procedures. The main question it aims to answer are: 1. What are the risk factors of peri-operative blood transfusion in open liver resection procedures 2. What are the difference outcomes between patients who receive blood transfusion and the other group. Researcher will compare perioperative factor and post operative outcomes between transfused and non-transfused group

Clinical Trial Description

After approval of the study protocol from the institutional review board of Chiangmai University (Approval number: ANE-2564-08020), we performed a retrospective review of all patients who underwent an elective open liver resection in our specialized hepato-biliary center from January 2006 through December 2017. This retrospective inquiry comprised 808 patients. The data was systematically retrieved from electronic medical records. Baseline characteristics including age, gender, body mass index (BMI), co-morbidity, American Society of Anesthesiologists (ASA) classification, diagnosis, hepatitis profile, Child-Pugh classification, cirrhosis, the largest tumor size, previous liver resection, and pre-operative laboratory investigations were collected. The following intra-operative data were collected: type of liver resection, hilar resection, vascular reconstruction, volume and type of fluid administration, estimated blood loss, packed red cell and blood product transfusion, and operation time. The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06189911
Study type	Observational
Source	Chiang Mai University
Contact
Status	Completed
Phase
Start date	January 1, 2006
Completion date	January 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05077124` - Safe and Timely Antithrombotic Removal (STAR) Registry
Completed	`NCT03622671` - Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting	N/A
Not yet recruiting	`NCT06060327` - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section	N/A
Completed	`NCT02509312` - Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery	Phase 4
Recruiting	`NCT05316649` - Blood Loss Quantification During Major Abdominal Surgery
Completed	`NCT03967171` - The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery	N/A
Completed	`NCT05273632` - Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)	N/A
Completed	`NCT05204056` - Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty	N/A
Active, not recruiting	`NCT03805607` - IV Ketorolac on Platelet Function Post-Cesarean Delivery	Phase 4
Completed	`NCT03249038` - Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.	N/A
Terminated	`NCT05093504` - Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)	N/A
Recruiting	`NCT06049160` - Comparative Study Between Preoperative and Postoperative Rectal Misoprostol	N/A
Completed	`NCT04976530` - Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)	N/A
Completed	`NCT03555383` - Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
Active, not recruiting	`NCT02438566` - Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery	Phase 3
Completed	`NCT04656067` - Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate	Phase 1/Phase 2